Takeda Pharmaceutical is a biopharmaceutical company with an innovative portfolio, engaged primarily in the research, development, production and marketing of pharmaceutical products. Co. has a geographically diversified global business and provides its prescription drugs in Japan and overseas. Co.'s principal pharmaceuticals are antidiabetic, antihypertensive medicine, drugs for multiple myeloma and mantle cell lymphoma, medicine for reflux esophagitis, and hyperuricemia treatment. Co. focuses its R&D activities on four core therapeutic areas of oncology, rare genetics and hemotology, neuroscience, gastroenterology, plasma-derived therapies and vaccines. When considering the Takeda Pharmaceutical Co Ltd stock dividend history, we have taken known splits into account, such that the TAK dividend history is presented on a split-adjusted ("apples to apples") basis. Takeda Pharmaceutical Co Ltd dividend history is presented both in graphical/chart form, and as a TAK dividend history data table along the right-hand column.
|
TAK Stock Dividend HistoryThe TAK dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable TAK historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the TAK dividend history record. Also see the TAK stock dividend history data table along the right-hand column below. |
|
|
Strong Buy (3.50 out of 4) 59th percentile
(ranked higher than approx. 59% of all stocks covered)
Analysts' Target Price: TAK Forecast Based on data provided by Zacks Investment Research via Quandl.com |